Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Stakeholders
2. Research & Forecasting
2.1. Research Methodology
2.1.1. Research Instruments
2.1.1.1. Secondary Instrument
2.1.1.2. Primary Instrument
2.1.2. Research Approaches
2.1.2.1. Bottom-up Approach
2.1.2.2. Top-down Approach
2.1.3. Research Reliability & Validity
2.1.4. Research Assumptions
2.1.5. Vendor Inclusion Criteria
2.2. Forecasting Methodology
2.2.1. Methodology for Market Estimation & Forecasting
2.2.2. Significance and Importance of the Market Estimation & Forecasting
3. Executive Summary
4. Premium Insight
4.1. Market Connectivity
4.2. Market Data Feed
4.3. Market Vendor Ranking Analysis
4.4. Market Dynamics
4.4.1. Drivers
4.4.1.1. Growing incidences of cancer
4.4.1.2. Adoption of targeted therapy over other treatment options
4.4.1.3. Development of bioinformatic tools enhancing the drug development process
4.4.1.4. Rise in healthcare expenditure and healthcare insurance
4.4.1.5. Technological advancement and R&D for the treatment of cancer
4.4.2. Restraints
4.4.2.1. Unfavorable regulatory and reimbursement scenario
4.4.3. Opportunities
4.4.3.1. Clinical trials to cure different cancers in immunotherapy
4.4.3.2. Companion diagnostics have the potential to improve immunotherapy efficacy and ensure greater safety
4.4.4. Challenges
4.4.4.1. Cancer limiting the immune response
4.5. Porter's Five Forces Analysis
4.5.1. Threat of New Entrants
4.5.2. Threat of Substitutes
4.5.3. Bargaining Power of Customers
4.5.4. Bargaining Power of Suppliers
4.5.5. Industry Rivalry
5. Global Immuno Oncology Assays Market, by Indication
5.1. Introduction
5.2. Bladder Cancer
5.3. Colorectal Cancer
5.4. Lung Cancer
5.5. Melanoma
6. Global Immuno Oncology Assays Market, by Product
6.1. Introduction
6.2. Consumables
6.3. Software
7. Global Immuno Oncology Assays Market, by Technology
7.1. Introduction
7.2. Flow Cytometry
7.3. Immunoassay
7.4. Ngs
7.5. PCR
8. Global Immuno Oncology Assays Market, by Application
8.1. Introduction
8.2. Clinical Diagnostics
8.3. Research
9. Global Immuno Oncology Assays Market, by Geography
9.1. Introduction
9.2. Americas Immuno Oncology Assays Market
9.2.1. Americas Immuno Oncology Assays Market, by Country
9.2.1.1. United States
9.2.1.2. Brazil
9.2.1.3. Canada
9.2.1.4. Mexico
9.2.1.5. Argentina
9.2.2. Americas Immuno Oncology Assays Market, by Indication
9.2.3. Americas Immuno Oncology Assays Market, by Product
9.2.4. Americas Immuno Oncology Assays Market, by Technology
9.2.5. Americas Immuno Oncology Assays Market, by Application
9.3. Europe, Middle East & Africa Immuno Oncology Assays Market
9.3.1. Europe, Middle East & Africa Immuno Oncology Assays Market, by Country
9.3.1.1. United Kingdom
9.3.1.2. Germany
9.3.1.3. France
9.3.1.4. Saudi Arabia
9.3.1.5. United Arab Emirates
9.3.1.6. Italy
9.3.1.7. Russia
9.3.2. Europe, Middle East & Africa Immuno Oncology Assays Market, by Indication
9.3.3. Europe, Middle East & Africa Immuno Oncology Assays Market, by Product
9.3.4. Europe, Middle East & Africa Immuno Oncology Assays Market, by Technology
9.3.5. Europe, Middle East & Africa Immuno Oncology Assays Market, by Application
9.4. Asia-Pacific Immuno Oncology Assays Market
9.4.1. Asia-Pacific Immuno Oncology Assays Market, by Country
9.4.1.1. China
9.4.1.2. Japan
9.4.1.3. India
9.4.1.4. Australia
9.4.2. Asia-Pacific Immuno Oncology Assays Market, by Indication
9.4.3. Asia-Pacific Immuno Oncology Assays Market, by Product
9.4.4. Asia-Pacific Immuno Oncology Assays Market, by Technology
9.4.5. Asia-Pacific Immuno Oncology Assays Market, by Application
10. 360iResearch Competitive Strategic Window
10.1. Introduction
10.1.1. Leverage Zone
10.1.2. Vantage Zone
10.1.3. Speculative Zone
10.1.4. Bottleneck Zone
11. 360iResearch FPNV Positioning Matrix
11.1. Introduction
11.2. 360iResearch Scores
11.2.1. Forefront
11.2.2. Pathfinders
11.2.3. Niche
11.2.4. Vital
11.3. Business Strategy
11.4. Product Satisfaction
12. Competitive News Feed Analysis
13. Company Usability Profiles
13.1. Agilent Technologies, Inc.
13.2. Foundation Medicine
13.3. HTG Molecular Diagnostics, Inc.
13.4. Illumina, Inc.
13.5. Merck
13.6. Nanostring Technologies, Inc.
13.7. Perkinelmer
13.8. Qiagen
13.9. Roche Diagnostics
13.10. Sartorius AG
13.11. Thermo Fisher Scientific, Inc.
14. Appendix
14.1. Top Reports
14.2. Author Details

LIST OF TABLES (40 TABLES)

TABLE 1. GLOBAL IMMUNO ONCOLOGY ASSAYS MARKET SIZE, 2016 - 2024 (USD MILLION)
TABLE 2. GLOBAL IMMUNO ONCOLOGY ASSAYS MARKET RANKING, BY VENDORS, 2017
TABLE 3. GLOBAL IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY INDICATION, 2016 - 2024 (USD MILLION)
TABLE 4. GLOBAL IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY BLADDER CANCER, BY GEOGRAPHY, 2016 - 2024 (USD MILLION)
TABLE 5. GLOBAL IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY COLORECTAL CANCER, BY GEOGRAPHY, 2016 - 2024 (USD MILLION)
TABLE 6. GLOBAL IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY LUNG CANCER, BY GEOGRAPHY, 2016 - 2024 (USD MILLION)
TABLE 7. GLOBAL IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY MELANOMA, BY GEOGRAPHY, 2016 - 2024 (USD MILLION)
TABLE 8. GLOBAL IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY PRODUCT, 2016 - 2024 (USD MILLION)
TABLE 9. GLOBAL IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY CONSUMABLES, BY GEOGRAPHY, 2016 - 2024 (USD MILLION)
TABLE 10. GLOBAL IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY SOFTWARE, BY GEOGRAPHY, 2016 - 2024 (USD MILLION)
TABLE 11. GLOBAL IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY TECHNOLOGY, 2016 - 2024 (USD MILLION)
TABLE 12. GLOBAL IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY FLOW CYTOMETRY, BY GEOGRAPHY, 2016 - 2024 (USD MILLION)
TABLE 13. GLOBAL IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY IMMUNOASSAY, BY GEOGRAPHY, 2016 - 2024 (USD MILLION)
TABLE 14. GLOBAL IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY NGS, BY GEOGRAPHY, 2016 - 2024 (USD MILLION)
TABLE 15. GLOBAL IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY PCR, BY GEOGRAPHY, 2016 - 2024 (USD MILLION)
TABLE 16. GLOBAL IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY APPLICATION, 2016 - 2024 (USD MILLION)
TABLE 17. GLOBAL IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY CLINICAL DIAGNOSTICS, BY GEOGRAPHY, 2016 - 2024 (USD MILLION)
TABLE 18. GLOBAL IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY RESEARCH, BY GEOGRAPHY, 2016 - 2024 (USD MILLION)
TABLE 19. GLOBAL IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY GEOGRAPHY, 2016 - 2024 (USD MILLION)
TABLE 20. AMERICAS IMMUNO ONCOLOGY ASSAYS MARKET SIZE, 2016 - 2024 (USD MILLION)
TABLE 21. AMERICAS IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY INDICATION, 2016 - 2024 (USD MILLION)
TABLE 22. AMERICAS IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY PRODUCT, 2016 - 2024 (USD MILLION)
TABLE 23. AMERICAS IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY TECHNOLOGY, 2016 - 2024 (USD MILLION)
TABLE 24. AMERICAS IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY APPLICATION, 2016 - 2024 (USD MILLION)
TABLE 25. EUROPE, MIDDLE EAST & AFRICA IMMUNO ONCOLOGY ASSAYS MARKET SIZE, 2016 - 2024 (USD MILLION)
TABLE 26. EUROPE, MIDDLE EAST & AFRICA IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY INDICATION, 2016 - 2024 (USD MILLION)
TABLE 27. EUROPE, MIDDLE EAST & AFRICA IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY PRODUCT, 2016 - 2024 (USD MILLION)
TABLE 28. EUROPE, MIDDLE EAST & AFRICA IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY TECHNOLOGY, 2016 - 2024 (USD MILLION)
TABLE 29. EUROPE, MIDDLE EAST & AFRICA IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY APPLICATION, 2016 - 2024 (USD MILLION)
TABLE 30. ASIA-PACIFIC IMMUNO ONCOLOGY ASSAYS MARKET SIZE, 2016 - 2024 (USD MILLION)
TABLE 31. ASIA-PACIFIC IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY INDICATION, 2016 - 2024 (USD MILLION)
TABLE 32. ASIA-PACIFIC IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY PRODUCT, 2016 - 2024 (USD MILLION)
TABLE 33. ASIA-PACIFIC IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY TECHNOLOGY, 2016 - 2024 (USD MILLION)
TABLE 34. ASIA-PACIFIC IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY APPLICATION, 2016 - 2024 (USD MILLION)
TABLE 35. 360IRESEARCH SCORES FOR FOREFRONT IN IMMUNO ONCOLOGY ASSAYS MARKET
TABLE 36. 360IRESEARCH SCORES FOR PATHFINDERS IN IMMUNO ONCOLOGY ASSAYS MARKET
TABLE 37. 360IRESEARCH SCORES FOR NICHE IN IMMUNO ONCOLOGY ASSAYS MARKET
TABLE 38. 360IRESEARCH SCORES FOR VITAL IN IMMUNO ONCOLOGY ASSAYS MARKET
TABLE 39. 360IRESEARCH FPNV POSITIONING MATRIX BUSINESS STRATEGY FOR IMMUNO ONCOLOGY ASSAYS MARKET
TABLE 40. 360IRESEARCH FPNV POSITIONING MATRIX PRODUCT SATISFACTION FOR IMMUNO ONCOLOGY ASSAYS MARKET

LIST OF FIGURES (34 TABLES)

FIGURE 1. GLOBAL IMMUNO ONCOLOGY ASSAYS MARKET: YEARS CONSIDERED FOR THE STUDY
FIGURE 2. GLOBAL IMMUNO ONCOLOGY ASSAYS MARKET: KEY RESEARCH METHODOLOGY
FIGURE 3. GLOBAL IMMUNO ONCOLOGY ASSAYS MARKET: KEY RESEARCH INSTRUMENTS
FIGURE 4. GLOBAL IMMUNO ONCOLOGY ASSAYS MARKET: KEY SECONDARY INSTRUMENT SOURCES
FIGURE 5. GLOBAL IMMUNO ONCOLOGY ASSAYS MARKET: KEY POTENTIAL RESPONDENTS
FIGURE 6. GLOBAL IMMUNO ONCOLOGY ASSAYS MARKET: KEY BREAKDOWN OF PRIMARY INSTRUMENT
FIGURE 7. GLOBAL IMMUNO ONCOLOGY ASSAYS MARKET: KEY RESEARCH APPROACHES
FIGURE 8. GLOBAL IMMUNO ONCOLOGY ASSAYS MARKET: KEY DATA TRIANGULATION
FIGURE 9. GLOBAL IMMUNO ONCOLOGY ASSAYS MARKET: KEY RESEARCH ASSUMPTIONS
FIGURE 10. IMMUNO ONCOLOGY ASSAYS MARKET: KEY MARKET CONNECTIVITY
FIGURE 11. GLOBAL IMMUNO ONCOLOGY ASSAYS MARKET SIZE, 2016 - 2024 (USD MILLION)
FIGURE 12. GLOBAL IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY INDICATION, 2017 VS 2024 (USD MILLION)
FIGURE 13. GLOBAL IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY BLADDER CANCER, BY GEOGRAPHY, 2017 VS 2024 (USD MILLION)
FIGURE 14. GLOBAL IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY COLORECTAL CANCER, BY GEOGRAPHY, 2017 VS 2024 (USD MILLION)
FIGURE 15. GLOBAL IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY LUNG CANCER, BY GEOGRAPHY, 2017 VS 2024 (USD MILLION)
FIGURE 16. GLOBAL IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY MELANOMA, BY GEOGRAPHY, 2017 VS 2024 (USD MILLION)
FIGURE 17. GLOBAL IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY PRODUCT, 2017 VS 2024 (USD MILLION)
FIGURE 18. GLOBAL IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY CONSUMABLES, BY GEOGRAPHY, 2017 VS 2024 (USD MILLION)
FIGURE 19. GLOBAL IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY SOFTWARE, BY GEOGRAPHY, 2017 VS 2024 (USD MILLION)
FIGURE 20. GLOBAL IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY TECHNOLOGY, 2017 VS 2024 (USD MILLION)
FIGURE 21. GLOBAL IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY FLOW CYTOMETRY, BY GEOGRAPHY, 2017 VS 2024 (USD MILLION)
FIGURE 22. GLOBAL IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY IMMUNOASSAY, BY GEOGRAPHY, 2017 VS 2024 (USD MILLION)
FIGURE 23. GLOBAL IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY NGS, BY GEOGRAPHY, 2017 VS 2024 (USD MILLION)
FIGURE 24. GLOBAL IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY PCR, BY GEOGRAPHY, 2017 VS 2024 (USD MILLION)
FIGURE 25. GLOBAL IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY APPLICATION, 2017 VS 2024 (USD MILLION)
FIGURE 26. GLOBAL IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY CLINICAL DIAGNOSTICS, BY GEOGRAPHY, 2017 VS 2024 (USD MILLION)
FIGURE 27. GLOBAL IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY RESEARCH, BY GEOGRAPHY, 2017 VS 2024 (USD MILLION)
FIGURE 28. GLOBAL IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY GEOGRAPHY, 2017 (USD MILLION)
FIGURE 29. 360IRESEARCH COMPETITIVE STRATEGIC WINDOW FOR GLOBAL IMMUNO ONCOLOGY ASSAYS MARKET, BY INDICATION, 2024
FIGURE 30. 360IRESEARCH COMPETITIVE STRATEGIC WINDOW FOR GLOBAL IMMUNO ONCOLOGY ASSAYS MARKET, BY PRODUCT, 2024
FIGURE 31. 360IRESEARCH COMPETITIVE STRATEGIC WINDOW FOR GLOBAL IMMUNO ONCOLOGY ASSAYS MARKET, BY TECHNOLOGY, 2024
FIGURE 32. 360IRESEARCH COMPETITIVE STRATEGIC WINDOW FOR GLOBAL IMMUNO ONCOLOGY ASSAYS MARKET, BY APPLICATION, 2024
FIGURE 33. 360IRESEARCH COMPETITIVE STRATEGIC WINDOW FOR GLOBAL IMMUNO ONCOLOGY ASSAYS MARKET, BY GEOGRAPHY, 2024
FIGURE 34. 360IRESEARCH FPNV POSITIONING MATRIX FOR IMMUNO ONCOLOGY ASSAYS MARKET